Document Detail


From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics.
MedLine Citation:
PMID:  21365387     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Aim of the review The translation of evidence based medicine to a specific patient presents a considerable challenge. We present by means of the examples nortriptyline, tramadol, clopidogrel, coumarins, abacavir and antipsychotics the discrepancy between available pharmacogenetic information and its implementation in daily clinical practice. Method Literature review. Results A mechanism based approach may be helpful to personalize medicine for the individual patient to which pharmacogenetics may contribute significantly. The lack of consistency in what we accept in bioequivalence and in pharmacogenetics of drug metabolising enzymes is discussed and illustrated with the example of nortriptyline. The impact of pharmacogenetics on examples like tramadol, clopidogrel, coumarins and abacavir is described. Also the present status of the polymorphisms of 5-HT2A and C receptors in antipsychotic-induced weight gain is presented as a pharmacodynamic example with until now a greater distance to clinical implementation. Conclusion The contribution of pharmacogenetics to tailor-made pharmacotherapy, which especially might be of value for patients deviating from the average, has not yet reached the position it seems to deserve.
Authors:
Bob Wilffert; Jesse Swen; Hans Mulder; Daan Touw; Anke-Hilse Maitland-Van der Zee; Vera Deneer;
Related Documents :
21321447 - Application of terahertz absorption spectroscopy to evaluation of aging variation of me...
21275037 - The potential for bias in reporting of industry-sponsored clinical trials.
1461107 - Sir william osler--contrasts between the saint-like legend and the rough-edged man.
7809237 - Surgical alteration of appearance among primitive societies in new guinea.
19627977 - Sports and performing arts medicine: 5. special populations.
9879237 - Localized complications from local anesthesia.
Publication Detail:
Type:  Journal Article     Date:  2011-02-11
Journal Detail:
Title:  International journal of clinical pharmacy     Volume:  33     ISSN:  2210-7711     ISO Abbreviation:  Int J Clin Pharm     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-03-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101554912     Medline TA:  Int J Clin Pharm     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  3-9     Citation Subset:  IM    
Affiliation:
Department of Quality and Patientsafety, Zorggroep Noorderbreedte, P.O. Box 888, 8901 BR, Leeuwarden, The Netherlands, B.Wilffert@ZNB.NL.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gonococcal resistance: are cephalosporins next?
Next Document:  Clinical applications of pharmacogenomics guided warfarin dosing.